Abbott changed the playing field. |
After all the noise they made, there would certainly be a lot of questions asked (if they raised their bid). |
Boston Scientific will do everything in its power to reach a deal with Guidant. |
But that is an awfully long time to look out for pharmaceuticals. |
I certainly think it could be a stand-alone company. I'm not certain it should be. |
I don't believe these things are going to matter for Boston Scientific. This is a strategic deal for them and these are small perturbations along the way. |
I don't think it's a sure thing by any stretch, but I think they have a good chance of making it. |
I don't think there's much risk to employees ? especially the Minnesota contingent. |
I have a feeling that Temecula is pretty safe. |
I haven't heard from a single Guidant shareholder who doesn't like the Boston Scientific deal. |
I think investors do take insider buying as a good sign, and I think they especially wanted Boston Scientific to do it. |
I think it's an amazing turn of events. |
I think of all the pieces, it's pharmaceuticals that are hurting them the most. |
I think there are some actions the company will have to take and some expenses the company will have to incur that will make it tough. I still think given those parameters, it can be, stay and remain an independent company and eventually flourish. |
I think they (St. Jude) definitely look like they are in play. They certainly would be an attractive candidate. |